| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.4M | +21.4% |
| Cost of Revenue | $5.5M | +25.5% |
| Gross Profit | $13.9M | +19.9% |
| R&D Expense | $17.7M | +25.1% |
| SG&A Expense | $26.1M | -37.0% |
| Operating Income | -$56.7M | +21.9% |
| Pre-tax Income | -$66.4M | +7.2% |
| Income Tax | -$65K | +95.4% |
| Net Income | -$63.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.2M | -61.4% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $3.2M | +0.3% |
| Inventory | $2.4M | +23.6% |
| Current Assets | $29.9M | -71.8% |
| Total Assets | $57.6M | -63.2% |
| Current Liabilities | $24.7M | -8.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.0M | +8.5% |
| Capital Expenditures | $245K | -29.2% |
| Investing Cash Flow | $36.4M | +168.0% |
| Financing Cash Flow | -$34.6M | -127.7% |
| Free Cash Flow | -$34.2M | +8.7% |
| +8.3% |
| EPS (Basic) | -$34.12 | -4638.9% |
| EPS (Diluted) | -$34.12 | -4638.9% |
| Total Liabilities |
| $25.5M |
| -10.4% |
| Stockholders' Equity | $32.2M | -60.6% |